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Obstructive sleep apnoeaObstructive sleep apnoea (OSA) is associated with an increase in the number of bursts of muscle sympathetic
nerve activity (MSNA), leading to neurogenic hypertension. Continuous positive airway pressure (CPAP) is the
most effective and widely used treatment for preventing collapse of the upper airway in OSA. In addition to
improving sleep, CPAP decreases daytimeMSNA towards control levels. It remains unknownhow this restoration
of MSNA occurs, in particular whether CPAP treatment results in a simple readjustment in activity of those brain
regions responsible for the initial increase in MSNA or whether other brain regions are recruited to over-ride
aberrant brain activity. By recording MSNA concurrently with functional Magnetic Resonance Imaging (fMRI),
we aimed to assess brain activity associatedwith each individual subject3s patterns of MSNA prior to and following
6 months of CPAP treatment. Spontaneous fluctuations in MSNA were recorded via tungsten microelectrodes
inserted into the common peroneal nerve in 13 newly diagnosed patients with OSA before and after 6 months of
treatment with CPAP and in 15 healthy control subjects while lying in a 3 T MRI scanner. Blood Oxygen Level
Dependent (BOLD) contrast gradient echo, echo-planar images were continuously collected in a 4 s ON, 4 s OFF
(200 volumes) sampling protocol. MSNA was significantly elevated in newly diagnosed OSA patients compared
to control subjects (55±4 vs 26±2 bursts/min). Fluctuations in BOLD signal intensity inmultiple regions covaried
with the intensity of the concurrently recorded bursts ofMSNA. Therewas a significant fall inMSNA after 6months
of CPAP (39± 2 bursts/min). The reduction in restingMSNAwas coupledwith significant falls in signal intensity in
precuneus bilaterally, the left and right insula, right medial prefrontal cortex, right anterior cingulate cortex, right
parahippocampus and the left and right retrosplenial cortices. These data support our contention that functional
changes in these suprabulbar sites are, via projections to the brainstem, driving the augmented sympathetic outflow
to the muscle vascular bed in untreated OSA.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Obstructive sleep apnoea (OSA) is characterized by repetitive
complete or partial collapse of the upper airway and cessation of airflow
during sleep. It is associated with significantly increased daytime
muscle sympathetic nerve activity (MSNA; Carlson et al., 1993, 1996;
Elam et al., 2002; Fatouleh and Macefield, 2014a; Hedner et al., 1988,
1995; Imadojemu et al., 2007; Narkiewitz et al., 1998, 1999;
Narkiewicz and Somers, 2003; Somers et al., 1995), thought to result
from the repetitive intermittent periods of hypoxemia during sleep
and brain alterations that likely result (Lanfranchi and Somers, 2001;sity of Western Sydney, Locked
4654; fax: +61 2 9852 4701.
ld).
. This is an open access article underNieto et al., 2000; Peppard et al., 2000). Despite the detrimental effects
of increased MSNA on an individual3s health, and the elevated risk of
future adverse cardiovascular events, very little is known about the
underlying mechanisms responsible for increased daytime MSNA in
individuals with OSA.
We have recently used functional Magnetic Resonance Imaging
(fMRI), coupled with concurrent recordings of MSNA, to show that the
elevatedMSNA in OSA subjects is associated with altered signal intensity
in a number of brain regions (Fatouleh et al., 2014b; Lundblad et al.,
2014). These include discrete sites within the prefrontal, cingulate and
precuneus cortices, as well as the retrosplenial cortex, caudate nucleus,
hippocampus and parahippocampal regions (Fatouleh et al., 2014b), as
well as within the dorsolateral pons, rostral ventrolateral medulla,
medullary raphe and midbrain (Lundblad et al., 2014). In most of
these regions, signal intensity covaried with each burst of MSNA inthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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altered signal displayed altered grey matter volume, suggesting that
the altered cortical activity associatedwith increasedMSNA in OSA sub-
jects does not result directly from gross structural changes as a
consequence of repetitive hypoxic events during sleep.
It has been shown by a number of investigators that treatment of
OSA with continuous positive airway pressure (CPAP) is associated
with a decrease in daytime MSNA towards control levels, as long as
patients are compliant with the requirement to use CPAP every night
(Fatouleh et al., 2014a; Hedner et al., 1995; Imadojemu et al., 2007;
Narkiewicz et al., 1999; Waradekar et al., 1996). Indeed, patients with
OSA who did not receive CPAP and were followed up after 6 and
12 months showed no changes in baseline MSNA (Narkiewicz et al.,
1999). It remains unknown how this reduction in MSNA occurs, in par-
ticular whether CPAP treatment results in a readjustment in activity of
those brain regions responsible for the initial increase in MSNA, or
whether other brain regions are recruited to over-ride the aberrant
brain activity. Elucidating the underlying mechanisms is important as
it may provide evidence that changes in brain activity in individuals
with conditions such as OSA are reversible by effective treatment
regimens. The aim of this investigation was to determine the effects
of CPAP on resting MSNA and associated brain activity patterns in
individuals with OSA. This was achieved by using concurrent recording
ofMSNA and fMRI to assess brain activity associatedwith each individual
subject3s sympathetic burst patterns, prior to and following 6 months of
CPAP treatment. We hypothesized that activity in those brain regions
associated with increased spontaneous MSNA, such as the prefrontal,
cingulate, and parahippocampus, would return to control levels as the
augmented MSNA seen in OSA returned to control levels following
CPAP treatment.2. Methods
2.1. Subjects
Data were obtained from 13 newly diagnosed patients with OSA (11
males, mean ± SEM age 53 ± 3, range 35–67 years) and 15 healthy
controls (12 males, age 53 ± 3, 35–68 years). These patients were a
subset of 17 reported previously (Fatouleh et al., 2014b; Lundblad,
2014). All patients had been evaluated at the sleep laboratory of the
Prince of Wales hospital for one night, monitored continuously for 8 h
using 12-channel polysomnography: EEG, ECG and submental EMG
recordings were obtained with surface electrodes, nasal and oral
airflow were monitored by thermistor and chest and abdominal move-
ments by respiratory inductive plethysmography. Oxyhaemoglobin
saturation was recorded overnight by finger pulse oximetry, a micro-
phone was placed on the lower neck to record snoring, and a camera
sensitive to ultraviolet light recorded the patient movements during
sleep. The overnight study was analysed offline and apnoeas
and hypopnoeas defined according to the international classification
of sleep disorders, by using Alice (Philips Medical Systems, The
Netherlands) and Somonologica (Medcare Flaga, Reykjavik, Iceland)
software. Therapeutic CPAP was determined during a full night with
respiratory monitoring. The treating specialist determined the CPAP
pressure that resulted in the cessation of the apnoeic events. Subse-
quently, subjects were treated at home with a CPAP machine individu-
ally calibrated for their optimal pressure (Series 9, ResMed, Sydney,
Australia). Compliance with prescribed CPAP therapy was based on an
automated download of the CPAPmachine at 1 and 6months, analysed
using ResScan software.
All control subjects undertook an overnight assessment using an
in-home device that monitored nasal airflow and oxygen saturation
(ApneaLink™; ResMed, Sydney, Australia). All procedures were ap-
proved by the Human Research Ethics Committees of the University of
Western Sydney and the University of New South Wales. Writtenconsent was obtained from all subjects in accordance with the Declara-
tion of Helsinki.
2.2. MRI and MSNA acquisition
Subjects lay supine on an MRI bed with their knees supported on a
foam cushion. An insulated tungsten microelectrode was inserted
percutaneously into a muscle fascicle of the common peroneal nerve
to record multiunit muscle sympathetic nerve activity (MSNA). A
second uninsulated microelectrode inserted subdermally nearby
(1–2 cm) acted as a reference electrode. Neural activity was amplified
(gain 100, band pass 0.1–5.0 kHz) using an MR compatible stainless
steel isolated headstage (NeuroAmp Ex. ADInstruments, Sydney,
Australia) and further amplified and filtered (total gain 2 × 104, band
pass 0.3–5.0 kHz). Data were recorded using a computer-based data
acquisition and analysis system (PowerLab 16S; ADInstruments,
Sydney, Australia).
In the laboratory ECG (0.3–1.0 kHz) was recorded with Ag–AgCl
surface electrodes on the chest and sampled at 2 kHz. Continuous
non-invasive blood pressure (BP) was recorded using radial arterial
tonometry (Colin 7000 NIBP, Colin Corp., Aichi, Japan), sampled at
400 Hz, and respiration was monitored from a piezoelectric transducer
around the abdomen (Pneumotrace, UFI). Spontaneous MSNA, heart
rate, respiration andBPwere recorded continuously for 10min of undis-
turbed rest, of which the final 5 min were used for analysis. Following
this period, the ECG electrodeswere removed, the BP recording stopped
and the subject wheeled to the scanner with the microelectrode in situ.
During scanning heart rate was monitored via an MR-compatible
piezoelectric pulse transducer on a fingerpad, and respiration was
monitored via an MR-compatible piezoelectric transducer around the
abdomen.
With each subject relaxed and enclosed in a 32-channel SENSE head
coil, a continuous series of 200 gradient echo echo-planar images,
sensitive to Blood Oxygen Level Dependent (BOLD) contrast were col-
lected (46 axial slices, TR = 8 s, TE = 40 ms, flip angle 90°, raw voxel
size=1.5mm3) using a 3 TeslaMRIwhole body scanner (Achieva, Phil-
lips Medical Systems). A 4 s-ON, 4 s-OFF protocol was used, withMSNA
measured during the 4 s-OFF period, and a whole-brain, 46 slice axial
volume were collected during the subsequent 4 s-ON period. A high-
resolution 3D T1-weighted anatomical image set was also collected
(turbo field echo; TE = 2.5 ms, TR = 5600 ms, flip angle = 8°, voxel
size 0.8 mm3).
2.3. MSNA processing
All MSNA signals were RMS-processed (root mean square, moving
average, time constant 200 ms). MSNA during the pre-MRI recording
period was quantified according to standard time-domain analysis of
the RMS-processed signal as burst frequency (bursts/min) and burst
incidence (bursts per 100 heart beats). Analysis of variance, coupled
with Tukey3s multiple comparisons test, was used to assess statistical
significance across each group. Significant differences between controls
andOSA subjects prior to CPAP treatmentwere determined (two-tailed,
two sample t-test, p b 0.05), and between OSA subjects prior to and
following CPAP treatment (two-tailed, paired t-test, p b 0.05). During
the fMRI scanning period, MSNA bursts were manually measured from
the RMS-processed version of the filtered nerve signal during the 4 s
inter-scan OFF period. This period was divided into 4 × 1 s intervals
and the total numbers of MSNA bursts for each 1 s epoch was
determined.
2.4. MRI processing
Details on the analytical approach can be found in our earlier studies
(James et al., 2013; Macefield and Henderson, 2010). Briefly, using
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normalized to the Montreal Neurological Institute (MNI) template,
and intensity normalized to eliminate slow signal intensity drift. No
subject displayed movement parameters greater than 1 mm in any
direction and, as a result, all subjects were used in the final analysis.
Scans were then smoothed by a 6 mm full-width half-maximum
Gaussian filter. BOLD signal intensity changes were measured during
the subsequent 4 s ON period to take into account the ~5 s neurovascular
coupling delay and the ~1 s required for the conduction of the sympathet-
ic bursts from the forebrain to the peripheral recording site (Fig. 1). Brain
imageswere collected in a caudal to rostral sequence, extending from the
medulla to the vertex of the cerebral cortex. This meant that the first set
of scans in the 46-slice scanning sequence included the brainstem, while
subsequent slices included progressively more rostral structures. Given
that we had previously performed high-resolution imaging of the
brainstem in OSA patients (Lundblad et al., 2014), in the current investi-
gation we focused on brain regions rostral to the midbrain (seconds 2, 3
and 4). Based on the 4 s temporal delay noted above, in each individual
subject the number of MSNA bursts during the corresponding 1 s epoch
in each of these 1 s periods was determined and a 200 time point
model derived for each individual subject for the 2nd, 3rd and 4th second
time periods. That is, for each brain volume, if an MSNA burst occurred a
“1”was entered into the model and if no MSNA burst occurred a “0”was
entered. In this way a 200 volumemodel was created for the 2nd second
of the 200, 4 s fMRI collection periods. The same procedure was then
performed for the 3rd and 4th second periods so that, for each subject,
three ×200 volumeMSNAmodelswere used to determine signal intensi-
ty changes during MSNA bursts in each corresponding caudal-rostral
section of the brain. It is important to note that this was not a region-
of-interest (ROI) study: any change in BOLD signal intensity occurring
in the volume of brain captured in one of the 1-s periods simplyFig. 1. Concurrentmicroneurography and functional magnetic resonance imaging (fMRI) proce
an individual subject. Note that during each 8 s period, the initial 4 s does not contain scanner a
The lower trace shows RMS (root mean square) nerve activity in which MSNA bursts are clearl
the grey shading. (B) A plot of the 200 volume repeated box-car model indicating whenMSNA
Each MSNA burst is represented by a single box-car. (C) A sagittal fMRI slice indicating the reg“popped-out” because its signal was temporally coupled to the corre-
sponding burst of MSNA.
Changes in BOLD signal intensity that matched each individual
subject3s MSNA burst model were then determined. For each subject,
the 6 direction realignment parameters as well as cerebrospinal fluid
signal intensity derived froma 3mmsphere place in the lateral ventricle
were included as nuisance variables. Second level, random effects
analyses were performed to compare signal intensity changes during
each MSNA burst in OSA subjects prior to and following 6 months of
compliant CPAP treatment.We have previously shown that the anterior
cingulate cortex, medial prefrontal cortex, precuneus, retrosplenial
cortex and parahippocampus all displayed significantly elevate signal
intensity in OSA subjects prior to CPAP treatment compared with
controls (Fatouleh et al., 2014b). Given this we hypothesized that signal
intensity in these brain regions would be reversed and return towards
controls levels following 6months of CPAP treatment. As a consequence
we used small volume corrections (p b 0.05) to reduce the likelihood of
Type 1 errors. In addition, we used a minimum cluster extent of 20
contiguous voxels to reduce Type 1 errors.
Since we were essentially correlating on-going fluctuations in signal
intensity with spontaneous fluctuations in MSNA, and given that bursts
ofMSNAwere significantlymore frequent in OSA subjects prior to CPAP
treatment than after treatment and in controls, it is possible that
differences in contrast values between OSA before and after CPAP, and
compared with controls, may have been partially due to differences in
search models. To ensure that this was not the case, for each significant
cluster we extracted the raw signal intensity changes and compared
signal intensity during bursts ofMSNA to signal intensity during periods
where there were no bursts. We also extracted signal intensity changes
from these clusters in control subjects to assess differences between all
three groups. Significant differences in signal intensity between controlsdure. (A) Upper trace shows a rawmuscle sympathetic nerve activity (MSNA) recording in
rtifact (MSNA recording period) whereas the subsequent 4 s does (fMRI collection period).
y visible. During an 8 s period, the corresponding MSNA and fMRI periods are indicated by
bursts occurred during the 2nd second period for each of the two hundred fMRI Volumes.
ion during which the 2nd second collection period occurred.
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subjects post-CPAP were determined (two-tailed, two sample t-test,
p b 0.05), and also between OSA subjects prior to and following CPAP
treatment (two-sample, paired t-test, p b 0.05).
3. Results
Based on overnight polysomnography, all OSA subjects were diag-
nosed with mild to severe OSA. Based on apnoea–hypopnoea indices
(AHI: mild = 5–15 events/h, moderate = 15–30, severe = N30), two
subjects were diagnosed with mild, one with moderate and 10 with
severe OSA (AHI range 7–62; AHI 38 ± 5). In OSA subjects, the
minimum SaO2 on the night of polysomnography was 83 ± 2% (range
67–93%), baseline SaO2 during wakefulness was 95 ± 1% (range
91–99%), and the baseline Epworth Sleep Scale score was 9 ± 1
(range 3–19). We monitored compliance during the 6 months CPAP
treatment period and found that OSA patients used CPAP for an average
of 6.0±0.4 h/night, as reported by theResScan software. Also as report-
ed by the software, there was a significant reduction in AHI after
6months of compliant treatment (AHI range 1–21; AHI 4± 2). Further-
more, during the CPAP treatment period, therewas no significant change
in BMI in OSA subjects (BMI: pre-CPAP 31 ± 2, post-CPAP 33 ± 2; p=
0.7).
The mean AHI for the control subjects following an in-home
overnight assessment of sleep patterns was 3± 1. Overnight monitoring
of sleepwasmade at variable times after the scanning had been conduct-
ed, and revealed that, while the majority had an AHI of 1–3, three of the
control subjects had an AHI of 8, 9 and 10. Nevertheless, these subjects
were otherwise healthy and did not identify as snorers or report being
tired during the day; one subject reported drinking on the night of the
test, which may well have affected his sleep patterns. Given the absent
clinical history of sleep disorders, it was not deemed necessary to under-
take a full polysomnographic assessment in these individuals because
they were symptom-free and normotensive. Although there was no sig-
nificant difference in age between OSA and control subject groups (two
sample t-test; p N 0.05), as expected there was a significant difference
in bodymass index (BMI: pre-CPAP 31±2, controls 24±1, p=0.0005).
3.1. Physiology
Cardiovascular parameters are provided in Table 1. During the phys-
iology recording session, compared to controls, OSA patients prior to
CPAP treatment had significantly elevated systolic and diastolic
pressures and MSNA burst frequency and burst incidence. In contrast,
there was no significant difference in heart rate. Six months of compliant
CPAP treatment resulted in a significant reduction in resting MSNA burst
frequency and burst incidence in all 13 OSA subjects. Nevertheless,
despite a significant reduction in MSNA, CPAP treatment did not have a
significant effect on blood pressure or heart rate. Fig. 2 shows a recording
of MSNA during fMRI in one subject with OSA prior to and followingTable 1
Cardiovascular parameters (mean ± SEM) of healthy control subjects, obstructive sleep
apnoea (OSA) patients prior to (OSA-0M), and following 6months (OSA-6M) of treatment
with continuous positive airway pressure (CPAP) collected immediately prior to the MRI
scanning session. Statistical comparisons (ANOVA) of cardiovascular parameters in OSA
subjects compared with the control group (*p b 0.05, **p b 0.01, ****p b 0.0001) and com-







Systolic pressure (mm Hg) 118 ± 4 141 ± 5*** 136 ± 5*
Diastolic pressure (mm Hg) 67 ± 3 82 ± 2** 76 ± 3
Heart rate (beats/min) 67 ± 4 72 ± 3 70 ± 2
Burst incidence (bursts/100 beats) 40 ± 2 80 ± 6**** 56 ± 4* ++
Burst frequency (burst/min) 26 ± 2 55 ± 4**** 39 ± 2** +++6months of CPAP; it can be seen that there are dramatically fewer bursts
of MSNA after CPAP treatment.
3.2. Changes in BOLD signal intensity
Voxel-by-voxel comparison of MSNA-related BOLD signal intensity
changes pre- and post-CPAP treatment revealed that the reduction in
resting MSNA was coupled with significant changes in signal intensity
in a number of brain regions (Fig. 3, Table 2). Significantly reduced
signal-intensity changes post-CPAP compared with pre-CPAP occurred
in the region of the precuneus bilaterally, the left and right insula,
right medial prefrontal cortex (mPFC), right anterior cingulate cortex
(ACC), right parahippocampus and the left and right retrosplenial
cortices.
Direct comparison of percentage changes in signal intensity
during MSNA bursts, compared with periods of no bursts, showed
that CPAP significantly reduced signal intensity within all of these
brain regions (Fig. 4; mean ± SEM signal intensity pre-CPAP vs
post-CPAP: precuneus: 0.22 ± 0.05 vs −0.06 ± 0.05, p = 0.0001;
left insula: 0.18 ± 0.03 vs −0.09 ± 0.06, p = 0.001; right insula:
0.18 ± 0.04 vs −0.05 ± 0.03, p = 0.0005; right mPFC: 0.11 ± 0.05
vs−0.03 ± 0.06, p = 0.02; right ACC: 0.07 ± 0.04 vs−0.06 ± 0.05,
p = 0.01; right parahippocampus: 0.08 ± 0.04 vs −0.10 ± 0.06,
p = 0.008; left retrosplenial cortex: 0.18 ± 0.04 vs −0.04 ± 0.03,
p = 0.0006; right retrosplenial cortex: 0.16 ± 0.03 vs −0.12 ± 0.05,
p = 0.0003).
In all of these brain regions, with the exception of the left insula and
right parahippocampus, MSNA-correlated signal intensity was signifi-
cantly increased in OSA subjects pre-CPAP compared with controls
(controls vs OSA pre-CPAP: precuneus:−0.04 ± 0.07 vs 0.22 ± 0.05,
p=0.004; left insula: 0.09± 0.08 vs 0.18± 0.03, p=0.19; right insula:
0.01 ± 0.07 vs 0.18 ± 0.04, p = 0.03; right mPFC: −0.02 ± 0.05 vs
0.11 ± 0.05, p = 0.04; right ACC: −0.07 ± 0.06 vs 0.07 ± 0.04, p =
0.03; right parahippocampus: 0.01 ± 0.05 vs 0.08 ± 0.04, p= 0.14; left
retrosplenial cortex: −0.10 ± 0.07 vs 0.18 ± 0.04, p = 0.002; right
retrosplenial cortex:−0.09 ± 0.07 vs 0.16 ± 0.03, p= 0.006). Further-
more, within all of these brain regions signal intensity returned towards
control levels post-CPAP, with signal intensity in the left insult being
below control levels (controls vs OSA post-CPAP: precuneus: p= 0.45;
left insula: p= 0.04; right insula: p= 0.22; right mPFC: p= 0.38; right
ACC: p=0.44; right parahippocampus: p=0.29; left retrosplenial cortex:
p= 0.24; right retrosplenial cortex: p= 0.37).
4. Discussion
We have shown that the functional changes in the brain in patients
with obstructive sleep apnoea return to control levels after 6 months of
compliant CPAP treatment. We had previously reported, in the same
patients, that CPAP caused a significant fall in MSNA (Fatouleh et al.,
2014a), as had been shown by others (Hedner et al., 1995; Narkiewicz
et al., 1999; Waradekar et al., 1996). However, the reduction in MSNA
was not associated with a significant fall in blood pressure, as had
been shown previously by some investigators (Hedner et al., 1995;
Narkiewicz et al., 1999) but not others (Becker et al., 2003). While
MSNA fell significantly following 6 months of CPAP, it did not return
completely to control levels. Importantly, the fall in resting MSNA fol-
lowing CPAPwas associated with significant changes in BOLD signal in-
tensity within a number of brain regions, including precuneus
bilaterally, the left and right insula, right medial prefrontal cortex
(mPFC), right anterior cingulate cortex (ACC), right parahippocampus
and the left and right retrosplenial cortices.
We have previously used concurrent recording of MSNA and fMRI to
determine cortical and subcortical sites underlying the increase in
MSNA in OSA patients (Fatouleh et al., 2014b; Lundblad et al., 2014).
The results from this study confirm these previous findings and show
that the increase in MSNA in OSA before treatment is associated with
Fig. 2.Multiunit recording ofmuscle sympathetic nerve activity (MSNA) from a 50-year-oldmale patientwith obstructive sleep apnoea (OSA) during scanning of the brain, obtained prior
to (A) and following (B) 6 months of CPAP treatment. The mean-voltage neurogram is shown in the nerve RMS (root mean square) trace; this was used to quantify the number of sym-
pathetic bursts. The black areas represent the scanning artifacts. MSNA bursts were measured during the OFF periods. Resting levels of MSNA were greatly reduced following CPAP.
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cortex, mPFC, ACC and parahippocampus. Importantly, these increases
in signal intensity were reversed by 6 months of CPAP treatment. That
these signal intensity changes following CPAP treatment essentially
paralleled the changes in MSNA, despite the fact that blood pressure
remained elevated, strongly suggests that the functional changes in
the brain are responsible for the changes in muscle sympathetic
outflow.
We found a reduction in signal intensity in mPFC after CPAP
treatment of OSA to control levels. Previously, we showed an increase
in signal intensity in mPFC which covaried with MSNA in OSA subjects
(Fatouleh et al., 2014b). The mPFC is known to send projections to
specific nuclei in the brainstem related to control ofmuscle sympathetic
outflow, such as the nucleus tractus solitarius (NTS) and rostralventrolateral medulla (RVLM) (Sica et al., 2000a; Weisz et al., 2001).
Similarly, the precuneus is functionally coupled to the RVLM at rest in
healthy controls, suggesting that activity within these cortical regions
contributes to resting MSNA via the RVLM (James et al., 2013). In
summary, the reduction inMSNAwith CPAP is accompanied by reduced
activity in mPFC and the precuneus.
In addition to the functional changes in mPFC after therapy, CPAP
treatment displayed a reduction in MSNA-related signal intensity with-
in the ACC and the retrosplenial cortex. The role of ACC in sympathetic
control is of great interest (Beissner et al., 2013; Critchley et al., 2003;
Kimmerly et al., 2013): pyramidal neurons within the ACC project di-
rectly and indirectly to subcortical regions associated with homeostasis
and autonomic control, including the hypothalamus (Ongür et al.,
1998). Electrical stimulation of this brain region in experimental
Fig. 3. Brain regions in which fluctuations in BOLD signal intensity coupled to fluctuations in muscle sympathetic nerve activity (MSNA) were significantly different in subjects with ob-
structive sleep apnoea (OSA) prior to and following 6months of continuous positive airway pressure (CPAP) treatment. Cool color scale represents regions in which changes in signal in-
tensity during each burst of MSNA were significantly reduced following CPAP treatment. Significant clusters are overlaid onto a mean T1-weighted anatomical template image. Slice
locations in Montreal Neurological Institute space are indicated at the lower right of each image. ACC: anterior cingulate cortex, mPFC: medial prefrontal cortex.
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pressure (Ward, 1948) and ACC stimulation in humans causes prompt
and usually complete arrest of respiration, bradycardia and a gradual in-
crease in blood pressure (Pool and Ransohoff, 1949). Orthostatic
stressors which unload baroreceptors and increase MSNA are also asso-
ciated with increased ACC activity (Goswami et al., 2012; Macefield
et al., 2006), and lesions encompassing the ACC are associated with
disrupted sympathetic cardiovascular regulation and impaired
generation of cardiovascular arousal during cognitive efforts (Critchley
et al., 2003). Moreover, it has been shown that heart rate variability is as-
sociated with changes in activity within both the ACC and retrosplenial
cortex (Critchley et al., 2003).
In an animal model of OSA, 30 days of chronic intermittent hypoxia
evokes c-fos expression in the cingulate cortex (Sica et al., 2000b), and
in OSA subjects manoeuvres that evoke significant increases in blood
pressure and heart rate result in aberrant cardiovascular responses
associated with altered activity changes in brain regions, including the
ACC and retrosplenial cortex (Harper et al., 2003; Macey et al., 2013).
This combined evidence of the key role for the ACC and retrosplenial
cortex in autonomic circuitry raises the possibility that dysfunction in
these brain regions contributes to the sympathoexcitation in OSA; the
normalization of signal intensity within these brain regions followingTable 2
Location, T-score and cluster size for regions showing significant signal intensity differ-
ences that were coupled to spontaneous muscle sympathetic nerve activity in subjects
with obstructive sleep apnoea prior to, compared with after 6 months of continuous pos-
itive airway pressure treatment. Cluster locations are given inMontreal Neurological Insti-
tute (MNI) space.
Brain regions X Y Z T-score Cluster size
Insula 38 8 −16 4.04 116
Right −38 11 −17 3.81 29
Left −30 −24 16 4.49 70
Right anterior cingulate cortex 6 42 6 4.32 20
Right parahippocampus 24 −42 −11 3.64 26
Right medial prefrontal cortex 8 60 −2 3.78 22




9 −52 13 6.30 252
−14 −55 16 6.62 348
Precuneus 2 −63 30 5.22 923CPAP treatment further demonstrates their potential contribution to
the marked sympathoexcitation seen in OSA.
In contrast to the regional differences described above, although sig-
nal intensity decreased significantly following CPAP treatment in the
left insula and right parahippocampus, it was not different to controls
prior to treatment. Somewhat surprisingly, signal intensity declined
after CPAP treatment in both these regions to control levels in the right
parahippocampus, and even significantly more than controls in the left
insula. The insular cortex has been considered to play an important role
in autonomic control in humans (Oppenheimer et al., 1990) as well as
in animals; indeed, we know that baroreceptors project to the insular
cortex in the rat and monkey (Zhang and Oppenheimer, 1997, 2000a,
b), and that electrical stimulation of the anterior insula can elicit changes
in arterial pressure, heart rate and sympathetic activity (Butcher and
Cechetto, 1995). The insular cortex has been implicated in cardiovascular
regulation (Harper et al., 2003; Oppenheimer et al., 1996; Woo et al.,
2005, 2007); cardiovascular challenges — such as the Valsalva
manoeuvre, inspiratory-capacity apnoea, cold-pressor test, hand-grip
exercise and loaded breathing — all evoke increases in signal intensity
in the anterior insula (Harper et al. 2000, 2003; Henderson et al. 2002,
2004; Macey et al. 2002, 2003, 2012; Sander et al. 2010; Wong 2007a,b;
Woo et al. 2007). However, the precise route by which the insula alters
sympathetic outflow remains unknown. Although the insula does not
project directly to RVLM (Saper, 1982), electrical stimulation of the insula
excites some RVLM sympathoexcitatory neurons (Sun, 1992), so it must
achieve this via a polysynaptic pathway.
The parahippocampus has been always associated with cognitive
functions. However, electrical stimulation of this region in monkeys
evokes marked decreases in arterial pressure and bradycardia (Wall
and Davis, 1951). Additionally, animal experiments have documented
the presence of sympathetic-related neurons in this structure
(Westerhaus and Loewy, 2001), which suggest that this region forms
part of the higher-brain central autonomic network. Indeed, a recent
fMRI study showed altered signals in this brain region in OSA patients,
in comparison to a healthy control group, during static handgrip exercise
(Macey et al., 2013). Therefore, it is not unreasonable to posit that the
pathophysiological changes seen in this brain region in OSA might also
contribute to the elevatedmuscle sympathetic outflow. That BOLD signal
intensitywas back to control levels after CPAP treatment further supports
the idea that this region is functionally related to the altered sympathetic
outflow in OSA.
Fig. 4. Plots of percentage signal intensity (SI) changes in regions in which MSNA-locked changes in BOLD signal intensity were significantly different in subjects with obstructive sleep
apnoea (OSA) prior to and following 6months continuous positive airway pressure (CPAP) treatment. Graphs showmean (±SEM) SI changes duringMSNAbursts comparedwith periods
of no bursts in controls (black), OSA pre-CPAP (white) and OSA post-CPAP (grey). Note that CPAP treatment results in a significant reduction in signal intensity during eachMSNA burst in
all seven brain regions. Furthermore, these signal reductions return to control levels in all regions except for the left insula. * indicates p b 0.05.
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Given that MSNA is temporally coupled to BOLD signal intensity in
various discrete sites within the brain, that the activity within these re-
gions increased in OSA with the increase in MSNA, and that activity in
these areas decreased with the decrease in MSNA following CPAP treat-
ment, our current observations lend further support to our conclusion
that these suprabulbar sites are driving sympathetic outflow to the
muscle vascular bed via the brainstem. The findings also reinforce the im-
portance of CPAP in reducing the pathophysiology associated with un-
treated OSA.
Conflicts of interest
The authors report no competing interests.
Acknowledgments
This work was supported by the National Health and Medical
Research Council of Australia (grant 1007557). We are grateful to the
assistance provided by Elie Hammam in these experiments, and to
ResMed (Australia) for providing the CPAP machines for this study.References
Becker, H.F., Jerrentrup, A., Ploch, T., Grote, L., Penzel, T., Sullivan, C.E., Peter, J.H., 2003. Effect
of nasal continuous positive airway pressure treatment on blood pressure in patients
with obstructive sleep apnea. Circulation 107 (1), 68–73. http://dx.doi.org/10.1161/01.
CIR.0000042706.47107.7A12515745.
Beissner, F., Meissner, K., Bär, K.-J., Napadow, V., 2013. The autonomic brain: an activation
likelihood estimation meta-analysis for central processing of autonomic function.
J. Neurosci. 33 (25), 10503–10511. http://dx.doi.org/10.1523/JNEUROSCI.1103-13.
201323785162.
Butcher, K.S., Cechetto, D.F., 1995. Autonomic responses of the insular cortex in hypertensive
and normotensive rats. Am. J. Physiol. 268 (1 2), R214–RR2227840324.
Carlson, J.T., Hedner, J., Elam, M., Ejnell, H., Sellgren, J., Wallin, B.G., 1993. Augmented resting
sympathetic activity in awake patients with obstructive sleep apnea. Chest 103 (6),
1763–1768. http://dx.doi.org/10.1378/chest.103.6.17638404098.
Carlson, J.T., Hedner, J.A., Sellgren, J., Elam, M., Wallin, B.G., 1996. Depressed baroreflex sen-
sitivity in patients with obstructive sleep apnea. Am. J. Respir. Crit. Care Med. 154 (5),
1490–1496. http://dx.doi.org/10.1164/ajrccm.154.5.89127708912770.
Critchley, H.D., Mathias, C.J., Josephs, O., O’Doherty, J., Zanini, S., Dewar, B.-K., Cipolotti, L.,
Shallice, T., Dolan, R.J., 2003. Human cingulate cortex and autonomic control:
converging neuroimaging and clinical evidence. Brain 126 (10), 2139–2152. http://dx.
doi.org/10.1093/brain/awg21612821513.
Elam, M., McKenzie, D., Macefield, V., 2002. Mechanisms of sympathoexcitation: single-unit
analysis of muscle vasoconstrictor neurons in awake OSAS subjects. J. Appl. Physiol. 93
(1), 297–303. http://dx.doi.org/10.1152/japplphysiol.00899.200112070217.
Fatouleh, R., McKenzie, D.K., Macefield, V.G., 2014a. Respiratory modulation of muscle
sympathetic nerve activity in obstructive sleep apnoea. Exp. Physiol. 99 (10),
1288–1298. http://dx.doi.org/10.1113/expphysiol.2013.07751124887112.
Fatouleh, R.H., Hammam, E., Lundblad, L.C., Macey, P.M., McKenzie, D.K., Henderson, L.A.,
Macefield, V.G., 2014b. Functional and structural changes in the brain associatedwith
806 R.H. Fatouleh et al. / NeuroImage: Clinical 7 (2015) 799–806the increase in muscle sympathetic nerve activity in obstructive sleep apnea.
NeuroImage. Clin. 6, 275–283.
Friston, K.J., Holmes, A.P., Poline, J.B., Grasby, P.J., Williams, S.C., Frackowiak, R.S., Turner,
R., 1995. Analysis of fMRI time-series revisited. NeuroImage 2 (1), 45–53. http://dx.
doi.org/10.1006/nimg.1995.10079343589.
Goswami, R., Frances, M.F., Steinback, C.D., Shoemaker, J.K., 2012. Forebrain organization
representing baroreceptor gating of somatosensory afferents within the cortical auto-
nomic network. J. Neurophysiol. 108 (2), 453–466. http://dx.doi.org/10.1152/jn.
00764.201122514285.
Harper, R.M., Bandler, R., Spriggs, D., Alger, J.R., 2000. Lateralized andwidespread brain ac-
tivation during transient blood pressure elevation revealed by magnetic resonance
imaging. J. Comp. Neurol. 417 (2), 195–204. http://dx.doi.org/10.1002/(SICI)1096-
9861(20000207)417:2b195::AID-CNE5N3.0.CO;2-V10660897.
Harper, R.M., Macey, P.M., Henderson, L.A., Woo, M.A., Macey, K.E., Frysinger, R.C., Alger,
J.R., Nguyen, K.P., Yan-Go, F.L., 2003. FMRI responses to cold pressor challenges in
control and obstructive sleep apnea subjects. J. Appl. Physiol. 94 (4), 1583–1595.
http://dx.doi.org/10.1152/japplphysiol.00881.200212514164.
Hedner, J., Darpö, B., Ejnell, H., Carlson, J., Caidahl, K., 1995. Reduction in sympathetic activity
after long-term CPAP treatment in sleep apnoea: cardiovascular implications. Eur.
Respir. J. 8 (2), 222–229. http://dx.doi.org/10.1183/09031936.95.080202227758555.
Hedner, J., Ejnell, H., Sellgren, J., Hedner, T.,Wallin, G., 1988. Is high and fluctuating muscle
nerve sympathetic activity in the sleep apnoea syndrome of pathogenetic importance
for the development of hypertension? J Hypertens Suppl 6 (4), S529–SS531. http://
dx.doi.org/10.1097/00004872-198812040-001663241251.
Henderson, L.A., Macey, P.M., Macey, K.E., Frysinger, R.C., Woo, M.A., Harper, R.K., Alger,
J.R., Yan-Go, F.L., Harper, R.M., 2002. Brain responses associated with the valsalva
maneuver revealed by functional magnetic resonance imaging. J. Neurophysiol. 88
(6), 3477–3486. http://dx.doi.org/10.1152/jn.00107.200212466462.
Henderson, L.A., Richard, C.A., Macey, P.M., Runquist, M.L., Yu, P.L., Galons, J.-P., Harper,
R.M., 2004. Functional magnetic resonance signal changes in neural structures to
baroreceptor reflex activation. J. Appl. Physiol. 96 (2), 693–703. http://dx.doi.org/
10.1152/japplphysiol.00852.200314565965.
Imadojemu, V.A., Mawji, Z., Kunselman, A., Gray, K.S., Hogeman, C.S., Leuenberger, U.A.,
2007. Sympathetic chemoreflex responses in obstructive sleep apnea and effects of
continuous positive airway pressure therapy. Chest 131 (5), 1406–1413. http://dx.
doi.org/10.1378/chest.06-258017494791.
James, C.,Macefield, V.G., Henderson, L.A., 2013. Real-time imaging of cortical and subcortical
control of muscle sympathetic nerve activity in awake human subjects. NeuroImage 70,
59–65. http://dx.doi.org/10.1016/j.neuroimage.2012.12.04723287526.
Kimmerly, D.S., Morris, B.L., Floras, J.S., 2013. Apnea-induced cortical BOLD-fMRI and pe-
ripheral sympathoneural firing response patterns of awake healthy humans. PLOS
One 8 (12), e82525. http://dx.doi.org/10.1371/journal.pone.008252524358198.
Lanfranchi, P., Somers, V.K., 2001. Obstructive sleep apnea and vascular disease. Respir.
Res. 2 (6), 315–319. http://dx.doi.org/10.1186/rr7911737928.
Lundblad, L.C., Fatouleh, R.H., Hammam, E., McKenzie, D.K., Macefield, V.G., Henderson,
L.A., 2014. Brainstem changes associated with increased muscle sympathetic drive
in obstructive sleep apnoea. NeuroImage 103, 258–266. http://dx.doi.org/10.1016/j.
neuroimage.2014.09.03125255048.
Macefield, V.G., Gandevia, S.C., Henderson, L.A., 2006. Neural sites involved in the
sustained increase in muscle sympathetic nerve activity induced by inspiratory ca-
pacity apnea: a fMRI study. J. Appl. Physiol. 100 (1), 266–273. http://dx.doi.org/10.
1152/japplphysiol.00588.200516123207.
Macey, P.M., Henderson, L.A., Macey, K.E., Alger, J.R., Frysinger, R.C., Woo, M.A., Harper,
R.K., Yan-Go, F.L., Harper, R.M., 2002. Brain morphology associated with obstructive
sleep apnea. Am. J. Respir. Crit. Care Med. 166 (10), 1382–1387. http://dx.doi.org/
10.1164/rccm.200201-050OC12421746.
Macey, P.M., Kumar, R., Woo, M.A., Yan-Go, F.L., Harper, R.M., 2013. Heart rate responses
to autonomic challenges in obstructive sleep apnea. PLOS One 8 (10), e76631. http://
dx.doi.org/10.1371/journal.pone.007663124194842.
Macey, P.M., Macey, K.E., Henderson, L.A., Alger, J.R., Frysinger, R.C., Woo, M.A., Yan-Go, F.,
Harper, R.M., 2003. Functional magnetic resonance imaging responses to expiratory
loading in obstructive sleep apnea. Respir. Physiol. Neurobiol. 138 (2–3), 275–290.
http://dx.doi.org/10.1016/j.resp.2003.09.00214609516.
Macey, P.M., Wu, P., Kumar, R., Ogren, J.A., Richardson, H.L., Woo, M.A., Harper, R.M., 2012.
Differential responses of the insular cortex gyri to autonomic challenges. Auton.
Neurosci. 168 (1–2), 72–81. http://dx.doi.org/10.1016/j.autneu.2012.01.00922342370.
Narkiewicz, K., Kato, M., Phillips, B.G., Pesek, C.A., Davison, D.E., Somers, V.K., 1999.
Nocturnal continuous positive airway pressure decreases daytime sympathetic traffic
in obstructive sleep apnea. Circulation 100 (23), 2332–2335. http://dx.doi.org/10.
1161/01.CIR.100.23.233210587337.
Narkiewicz, K., Pesek, C.A., Kato, M., Phillips, B.G., Davison, D.E., Somers, V.K., 1998. Baro-
reflex control of sympathetic nerve activity and heart rate in obstructive sleep apnea.
Hypertens. 32 (6), 1039–1043. http://dx.doi.org/10.1161/01.HYP.32.6.10399856970.
Narkiewicz, K., Somers, V.K., 2003. Sympathetic nerve activity in obstructive sleep apnoea.
Acta Physiol. Scand. 177 (3), 385–390. http://dx.doi.org/10.1046/j.1365-201X.2003.
01091.x12609010.Nieto, F.J., Young, T.B., Lind, B.K., Shahar, E., Samet, J.M., Redline, S., D’Agostino, R.B.,
Newman, A.B., Lebowitz, M.D., Pickering, T.G., 2000. Association of sleep-disordered
breathing, sleep apnea, and hypertension in a large community-based study. Sleep
Heart Health Study. JAMA 283 (14), 1829–1836. http://dx.doi.org/10.1001/jama.
283.14.182910770144.
Ongür, D., An, X., Price, J.L., 1998. Prefrontal cortical projections to the hypothalamus in
macaque monkeys. J. Comp. Neurol. 401 (4), 480–505. http://dx.doi.org/10.1002/
(SICI)1096-9861(19981130)401:4b480::AID-CNE4N3.3.CO;2-69826274.
Oppenheimer, S.M., Cechetto, D.F., Hachinski, V.C., 1990. Cerebrogenic cardiac arrhythmias.
cerebral electrocardiographic influences and their role in sudden death. Arch. Neurol.
47 (5), 513–519. http://dx.doi.org/10.1001/archneur.1990.005300500290082185720.
Oppenheimer, S.M., Kedem, G., Martin, W.M., 1996. Left-insular cortex lesions perturb
cardiac autonomic tone in humans. Clin. Auton. Res. 6 (3), 131–140. http://dx.doi.
org/10.1007/BF022818998832121.
Peppard, P.E., Young, T., Palta, M., Skatrud, J., 2000. Prospective study of the association
between sleep-disordered breathing and hypertension. N. Engl. J. Med. 342 (19),
1378–1384. http://dx.doi.org/10.1056/NEJM20000511342190110805822.
Pool, J.L., Ransohoff, J., 1949. Autonomic effects on stimulating rostral portion of cingulate
gyri in man. J. Neurophysiol. 12 (6), 385–39215408005.
Sander, M., Macefield, V.G., Henderson, L.A., 2010. Cortical and brain stem changes in neural
activity during static handgrip andpostexercise ischemia in humans. J. Appl. Physiol. 108
(6), 1691–1700. http://dx.doi.org/10.1152/japplphysiol.91539.200820185626.
Saper, C.B., 1982. Convergence of autonomic and limbic connections in the insular cortex
of the rat. J. Comp. Neurol. 210 (2), 163–173. http://dx.doi.org/10.1002/cne.
9021002077130477.
Sica, A.L., Greenberg, H.E., Ruggiero, D.A., Scharf, S.M., 2000a. Chronic-intermittent
hypoxia: a model of sympathetic activation in the rat. Respir. Physiol. 121 (2–3),
173–184. http://dx.doi.org/10.1016/S0034-5687(00)00126-210963773.
Sica, A.L., Greenberg, H.E., Scharf, S.M., Ruggiero, D.A., 2000b. Immediate-early gene
expression in cerebral cortex following exposure to chronic-intermittent hypoxia.
Brain Res. 870 (1–2), 204–210. http://dx.doi.org/10.1016/S0006-8993(00)02170-
310869520.
Somers, V.K., Dyken, M.E., Clary, M.P., Abboud, F.M., 1995. Sympathetic neural mecha-
nisms in obstructive sleep apnea. J. Clin. Invest. 96 (4), 1897–1904. http://dx.doi.
org/10.1172/JCI1182357560081.
Sun, M.K., 1992. Medullospinal vasomotor neurones mediate hypotension from stimula-
tion of prefrontal cortex. J. Auton. Nerv. Syst. 38 (3), 209–217. http://dx.doi.org/10.
1016/0165-1838(92)90032-C1613210.
Wall, P.D., Davis, G.D., 1951. Three cerebral cortical systems affecting autonomic function.
J. Neurophysiol. 14 (6), 507–51714889304.
Waradekar, N.V., Sinoway, L.I., Zwillich, C.W., Leuenberger, U.A., 1996. Influence of treatment
onmuscle sympathetic nerve activity in sleep apnea. Am. J. Respir. Crit. CareMed. 153 (4
1), 1333–1338. http://dx.doi.org/10.1164/ajrccm.153.4.86165638616563.
Ward, A.A., 1948. The cingular gyrus, area 24. J. Neurophysiol. 11 (1), 13–2318921401.
Weisz, J., Emri, M., Fent, J., Lengyel, Z., Márián, T., Horváth, G., Bogner, P., Trón, L., Adám, G.,
2001. Right prefrontal activation produced by arterial baroreceptor stimulation: a PET
study. Neuroreport 12 (15), 3233–3238. http://dx.doi.org/10.1097/00001756-
200110290-0001811711862.
Westerhaus, M.J., Loewy, A.D., 2001. Central representation of the sympathetic nervous
system in the cerebral cortex. Brain Res. 903 (1–2), 117–127. http://dx.doi.org/10.
1016/S0006-8993(01)02453-211382395.
Wong, S.W., Kimmerly, D.S., Massé, N., Menon, R.S., Cechetto, D.F., Shoemaker, J.K., 2007a.
Sex differences in forebrain and cardiovagal responses at the onset of isometric
handgrip exercise: a retrospective fMRI study. J. Appl. Physiol. 103, 1402–1411.
Wong, S.W., Massé, N., Kimmerly, D.S., Menon, R.S., Shoemaker, J.K., 2007b. Ventral
medial prefrontal cortex and cardiovagal control in conscious humans. NeuroImage
35 (2), 698–708. http://dx.doi.org/10.1016/j.neuroimage.2006.12.02717291781.
Woo, M.A., Macey, P.M., Keens, P.T., Kumar, R., Fonarow, G.C., Hamilton, M.A., Harper,
R.M., 2005. Functional abnormalities in brain areas that mediate autonomic nervous
system control in advanced heart failure. J. Card. Fail. 11 (6), 437–446. http://dx.doi.
org/10.1016/j.cardfail.2005.02.00316105635.
Woo, M.A., Macey, P.M., Keens, P.T., Kumar, R., Fonarow, G.C., Hamilton, M.A., Harper,
R.M., 2007. Aberrant central nervous system responses to the valsalva maneuver in
heart failure. Cong. Heart Fail. 13, 29–35.
Zhang, Z., Oppenheimer, S.M., 1997. Characterization, distribution and lateralization of
baroreceptor-related neurons in the rat insular cortex. Brain Res. 760 (1–2),
243–250. http://dx.doi.org/10.1016/S0006-8993(97)00284-99237541.
Zhang, Z., Oppenheimer, S.M., 2000b. Electrophysiological evidence for reciprocal insulo-
insular connectivity of baroreceptor-related neurons. Brain Res. 863 (1–2), 25–41.
http://dx.doi.org/10.1016/S0006-8993(00)02068-010773190.
Zhang, Z.H., Oppenheimer, S.M., 2000a. Baroreceptive and somatosensory convergent
thalamic neurons project to the posterior insular cortex in the rat. Brain Res. 861
(2), 241–256. http://dx.doi.org/10.1016/S0006-8993(00)01990-910760486.
